35.350
+1,14%
2026-10-19
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +92.5% | +53.0% | 3 / 3 | -10.8% | +4.44 pp | +4.99 pp | +18.8% | 0.74 | 5.32 | 1.675 | −10,8% | 174 | +71,4% | 5.32 | 8.91 | −40,3% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 35.350 (close price on 2026-10-19)EPS (TTM): 6.641
Financial charts
1.Revenue & growth
VND bn1.667Q2/26
1.Revenue & growth
VND bn1.667Q2/26
2.Profit & growth
VND bn169Q2/26
3.Profit mix (Penman)
VND bn528Q2/26
4.Margins & cost structure
%13.4%Q2/26
5.Returns & cash cycle
% · days18.6%Q2/26
6.Earnings quality & cash
VND bn574Q2/26
7.Asset structure
VND bn5.438Q2/26
8.Funding & debt health
VND bn · times5.438Q2/26
9.Revenue backlog
VND bn13,8Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.591Q2/26
Adjusted EPS growth, latest quarter
111%
Average adjusted EPS growth, 3 quarters
59.0%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26